Angiotensin 1/2 (1-6): Benchmark Hexapeptide for Renin-Angiotensin System Research

Executive Summary: Angiotensin 1/2 (1-6) (Asp-Arg-Val-Tyr-Ile-His) is a highly pure hexapeptide derived from the N-terminus of angiotensin I and II, integral to the renin-angiotensin system (RAS) for vascular and renal regulation (Oliveira et al., 2025). This peptide potently induces vasoconstriction and stimulates aldosterone release, leading to increased blood pressure and sodium retention under defined physiological conditions (DOI:10.3390/ijms26136067). APExBIO's Angiotensin 1/2 (1-6) (SKU: A1048) achieves 99.85% purity and robust water solubility (≥62.4 mg/mL at 20°C), supporting reproducible workflows. Recent peer-reviewed evidence links N-terminal angiotensin fragments to SARS-CoV-2 spike–receptor interactions, expanding research relevance (Oliveira et al., 2025). This article provides atomic, citable benchmarks and clear integration guidelines for cardiovascular and renal research.

Biological Rationale

Angiotensin 1/2 (1-6) is a linear hexapeptide (sequence: Asp-Arg-Val-Tyr-Ile-His) generated by the proteolytic cleavage of angiotensinogen, a liver-derived glycoprotein (Oliveira et al., 2025). This cleavage is catalyzed by renin and angiotensin-converting enzymes (ACE) within the RAS. The RAS is the principal hormonal system for maintaining blood pressure and fluid-electrolyte balance (Redefining the Renin-Angiotensin System). Angiotensin 1/2 (1-6) is an N-terminal fragment of both angiotensin I (1-10) and angiotensin II (1-8), distinguished by the absence of the C-terminal Pro-Phe(-His-Leu) residues. It serves as a bioactive modulator of vascular tone, with vasoconstrictive effects and significant influence on aldosterone secretion by the adrenal cortex. These functionalities directly impact systemic blood pressure and sodium homeostasis, making Angiotensin 1/2 (1-6) a fundamental analyte and intervention in cardiovascular and renal research.

Mechanism of Action of Angiotensin 1/2 (1-6)

Angiotensin 1/2 (1-6) acts primarily via the classical RAS pathway. Upon endogenous or experimental administration, the peptide binds to vascular smooth muscle cell receptors, inducing vasoconstriction and elevating blood pressure. It also stimulates aldosterone synthesis and release from the adrenal cortex, enhancing sodium reabsorption in renal distal tubules (Oliveira et al., 2025). The molecular weight of the peptide is 801.89 Da. Its activity profile is mediated by the presence of a Tyr residue at position 4, a critical determinant for receptor interaction and downstream signaling. C-terminal truncation to the (1-6) form preserves vasoconstrictive and aldosterone-stimulating activity, as shown by antibody binding and cell-based assays (Oliveira et al., 2025). Notably, Angiotensin 1/2 (1-6) has been demonstrated to enhance binding between the SARS-CoV-2 spike protein and AXL receptor, paralleling the activity of full-length angiotensin II in this context. The peptide does not modulate spike–ACE2 or spike–NRP1 binding (Oliveira et al., 2025).

Evidence & Benchmarks

• Angiotensin 1/2 (1-6) increases vascular smooth muscle contraction in vitro at 1 μM in HBSS buffer, pH 7.4 (≥25°C) (Oliveira et al., 2025).
• Stimulates aldosterone release in rat adrenal cortex cell cultures at concentrations as low as 100 nM, with maximal effect at 10 μM (Oliveira et al., 2025).
• Exhibits water solubility ≥62.4 mg/mL and DMSO solubility ≥80.2 mg/mL at 20°C (manufacturer data: APExBIO).
• Enhances SARS-CoV-2 spike–AXL binding by 2-fold in antibody-based binding assays (cell-free, pH 7.4, 37°C) (Oliveira et al., 2025).
• Shows no effect on spike–ACE2 or spike–NRP1 binding at 10 μM (Oliveira et al., 2025).
• Presents at 99.85% purity with a molecular weight of 801.89 Da (manufacturer data: APExBIO).

This article extends mechanistic findings from "Angiotensin 1/2 (1-6): Mechanistic Insights for Renin-Ang..." by providing updated evidence on viral pathophysiology and peptide-receptor specificity, clarifying contexts where Angiotensin 1/2 (1-6) is mechanistically distinct from other RAS fragments.

For a scenario-driven laboratory guide to robust experimental design, see "Angiotensin 1/2 (1-6): Reliable Solutions for RAS Researc...", which this article supplements with atomic, peer-reviewed evidence for SARS-CoV-2 related workflows.

Applications, Limits & Misconceptions

Angiotensin 1/2 (1-6), as provided in the A1048 kit by APExBIO, is best suited for:

• Cardiovascular regulation studies, especially modeling vasoconstriction and blood pressure modulation.
• Renal function research requiring precise control of aldosterone and sodium transport mechanisms (Angiotensin 1/2 (1-6): Elevating Renin-Angiotensin System...—this article clarifies viral interaction data not covered in the linked piece).
• Hypertension research and pharmacodynamic profiling of RAS inhibitors.
• Dissecting the contribution of angiotensin fragments to SARS-CoV-2 pathogenesis, specifically spike–AXL interactions.

Common Pitfalls or Misconceptions

• Angiotensin 1/2 (1-6) does not activate the type 2 angiotensin II receptor (AT2R); its effects are primarily via AT1R or direct action on smooth muscle (DOI:10.3390/ijms26136067).
• It does not modulate SARS-CoV-2 spike binding to ACE2 or NRP1, only AXL (Oliveira et al., 2025).
• Peptide is unstable in ethanol and should not be dissolved or stored in ethanol-based buffers.
• Activity is lost if stored above -20°C or in solution for extended periods (>7 days at 4°C).
• Not suitable for direct therapeutic use; validated only for in vitro and ex vivo research.

Workflow Integration & Parameters

• Dissolve Angiotensin 1/2 (1-6) in water or DMSO to ≥1 mM stock concentration; filter-sterilize for cell culture applications.
• Recommended storage: -20°C as a solid. Reconstituted solutions: use within 48 hours for maximum activity.
• For vascular tone assays, use 1–10 μM range in HBSS or Krebs buffer, pH 7.4, 25–37°C.
• For aldosterone release studies, titrate from 100 nM to 10 μM in defined adrenal cell media.
• In SARS-CoV-2 spike–AXL binding assays, use 10 μM peptide in standard antibody-based protocols at 37°C, pH 7.4.

For advanced mechanistic protocols leveraging the peptide's high solubility and purity, see "Angiotensin 1/2 (1-6): Precision Tools for Vascular and R...", which this article updates by mapping viral pathogenesis contexts.

Conclusion & Outlook

Angiotensin 1/2 (1-6) (SKU: A1048, APExBIO) is a gold-standard reference for dissecting vascular, renal, and emerging viral mechanisms within the RAS. Its atomic, reproducible effects are validated by peer-reviewed evidence, supporting advanced cardiovascular and SARS-CoV-2 research. Future directions include mechanistic dissection of peptide modifications and clinical translation of RAS fragment modulators. For product specifications and ordering, consult APExBIO.